Skip to main content
. 2020 Nov 20;8(2):e001674. doi: 10.1136/jitc-2020-001674

Table 2.

Response to immunotherapy based on pretreatment BMI trend

Outcome Any decrease (n=308) No decrease (n=321) P value
Best overall response—no. (%) 0.04
 Complete response (CR) 31 (10.1) 37 (11.5)
 Partial response (PR) 54 (17.5) 85 (26.5)
 Stable disease (SD) 56 (18.2) 58 (18.1)
 Progressive disease (PD) 162 (52.6) 135 (42.1)
 Could not be evaluated 5 (1.6) 6 (1.9)
Objective response rate* 0.01
 No. (%) 85 (27.6) 122 (38.0)
 95% CI† 22.7 to 33.0 32.7 to 43.6
Disease control rate‡ 0.01
 No. (%) 141 (45.8) 180 (56.1)
 95% CI† 40.1 to 51.5 50.1 to 61.6

*Objective response rate was defined as the percentage of patients who had CR or PR.

†The 95% CIs were calculated using the Clopper-Pearson method.

‡Disease control rate was defined as the percentage of patients who had CR, PR or SD